AEON Biopharma Inc. - Ordinary Shares - Class A
AEON
Get informed when a big investor buys or sells
+ FollowMarket Cap$12.19M
Close$
$-5.54
2378.5% downside
Current Fair Value
2378.5% downsideOvervalued by 2378.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $12.19 Million |
|---|---|
| Enterprise Value | $11.53 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.95 |
| Beta | 0.69 |
| Outstanding Shares | 50,530,946 |
Return
| Return on Equity | 355.60% |
|---|---|
| Return on Assets | -924.25% |
| Return on Invested Capital | 1431.28% |
Valuation & Multiples
| P/E Ratio | -0.07 |
|---|---|
| PEG | 0.09 |
| Price to Sales | - |
| Price to Book Ratio | -0.24 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.56 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | -0.18 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 18, 2026
EPS Estimate
$-0.33
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 13, 2026
EPS Estimate
$-0.10
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.03%▼ 25.31% |
|---|---|
| Total Invested | $3,857▼ 99.96% |
| Investors Holding | 1▼ 22.00% |
ESG Score
No data